Annual Operating Expenses
$32.49 M
+$18.59 M+133.78%
31 December 2023
Summary:
Forte Biosciences annual total operating expenses is currently $32.49 million, with the most recent change of +$18.59 million (+133.78%) on 31 December 2023. During the last 3 years, it has risen by +$18.26 million (+128.37%). FBRX annual operating expenses is now at all-time high.FBRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$8.63 M
-$4.19 M-32.68%
30 September 2024
Summary:
Forte Biosciences quarterly total operating expenses is currently $8.63 million, with the most recent change of -$4.19 million (-32.68%) on 30 September 2024. Over the past year, it has dropped by -$1.59 million (-15.53%). FBRX quarterly operating expenses is now -32.68% below its all-time high of $12.82 million, reached on 30 June 2024.FBRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FBRX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +133.8% | -15.5% |
| 3 y3 years | +128.4% | +12.1% |
| 5 y5 years | - | +1161.5% |
FBRX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +133.8% | -32.7% | +243.2% |
| 5 y | 5 years | at high | +133.8% | -32.7% | +1161.5% |
| alltime | all time | at high | +133.8% | -32.7% | +1271.9% |
Forte Biosciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.63 M(-32.7%) |
| June 2024 | - | $12.82 M(+64.2%) |
| Mar 2024 | - | $7.80 M(+22.3%) |
| Dec 2023 | $32.49 M(+133.8%) | $6.38 M(-37.5%) |
| Sept 2023 | - | $10.22 M(+13.1%) |
| June 2023 | - | $9.03 M(+31.8%) |
| Mar 2023 | - | $6.86 M(+38.8%) |
| Dec 2022 | $13.90 M | $4.94 M(+44.3%) |
| Sept 2022 | - | $3.42 M(+13.3%) |
| June 2022 | - | $3.02 M(+20.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.51 M(-23.8%) |
| Dec 2021 | $21.49 M(+51.0%) | $3.30 M(-57.2%) |
| Sept 2021 | - | $7.70 M(+34.0%) |
| June 2021 | - | $5.75 M(+21.2%) |
| Mar 2021 | - | $4.74 M(+5.5%) |
| Dec 2020 | $14.22 M | $4.49 M(-10.3%) |
| Sept 2020 | - | $5.01 M(+85.7%) |
| June 2020 | - | $2.70 M(+33.1%) |
| Mar 2020 | - | $2.03 M(+196.3%) |
| Sept 2019 | - | $684.00 K(+8.7%) |
| June 2019 | - | $629.00 K |
FAQ
- What is Forte Biosciences annual total operating expenses?
- What is the all time high annual operating expenses for Forte Biosciences?
- What is Forte Biosciences annual operating expenses year-on-year change?
- What is Forte Biosciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Forte Biosciences?
- What is Forte Biosciences quarterly operating expenses year-on-year change?
What is Forte Biosciences annual total operating expenses?
The current annual operating expenses of FBRX is $32.49 M
What is the all time high annual operating expenses for Forte Biosciences?
Forte Biosciences all-time high annual total operating expenses is $32.49 M
What is Forte Biosciences annual operating expenses year-on-year change?
Over the past year, FBRX annual total operating expenses has changed by +$18.59 M (+133.78%)
What is Forte Biosciences quarterly total operating expenses?
The current quarterly operating expenses of FBRX is $8.63 M
What is the all time high quarterly operating expenses for Forte Biosciences?
Forte Biosciences all-time high quarterly total operating expenses is $12.82 M
What is Forte Biosciences quarterly operating expenses year-on-year change?
Over the past year, FBRX quarterly total operating expenses has changed by -$1.59 M (-15.53%)